![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 ACCORD HEALTHCARE LIMITED (2)
02 ASTELLAS PHARMA GmbH (3)
03 Accord Healthcare Ltd. (2)
04 Actavis Group PTC ehf (1) (2)
05 Astellas Pharma GmbH (2)
06 EG SpA (2)
07 MEDAC GMBH (2)
08 Mundipharma Medical Company Hamilton,Bermuda,Basel Branch (3)
09 The Fresenius Kabi Oncology Plc (2)
01 Bendamustine (17)
02 Bendamustine Hydrochloride (3)
01 Italy (9)
02 Norway (8)
03 Switzerland (3)
01 Bendamustina 100Mg 5 Units Parenteral Use (4)
02 Bendamustina 25Mg 20 Joined The Parenteral Use (1)
03 Bendamustina 25Mg 5 Units Parenteral Use (4)
04 Powder to concentrate to the infusion fluid, resolution (8)
05 Blank (3)